FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

34376311000001102: Xydalba 500mg powder for concentrate for solution for infusion vials (Cardiome UK Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 24-May 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
103920501000001114 Xydalba 500mg powder for concentrate for solution for infusion vials (Cardiome UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
109976301000001118 Xydalba 500mg powder for concentrate for solution for infusion vials (Correvio UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Xydalba 500mg powder for concentrate for solution for infusion vials (Cardiome UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Xydalba 500mg powder for concentrate for solution for infusion vials (Cardiome UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Xydalba 500mg powder for concentrate for solution for infusion vials (Cardiome UK Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring false Inferred relationship Existential restriction modifier
Xydalba 500mg powder for concentrate for solution for infusion vials (Cardiome UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Xydalba 500mg powder for concentrate for solution for infusion vials (Cardiome UK Ltd) Is a Dalbavancin 500mg powder for solution for infusion vials true Inferred relationship Existential restriction modifier
Xydalba 500mg powder for concentrate for solution for infusion vials (Cardiome UK Ltd) Has active ingredient Dalbavancin true Inferred relationship Existential restriction modifier
Xydalba 500mg powder for concentrate for solution for infusion vials (Cardiome UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Xydalba 500mg powder for concentrate for solution for infusion vials (Cardiome UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Xydalba 500mg powder for concentrate for solution for infusion vials (Cardiome UK Ltd) Has specific active ingredient Dalbavancin hydrochloride true Inferred relationship Existential restriction modifier
Xydalba 500mg powder for concentrate for solution for infusion vials (Cardiome UK Ltd) Has dispensed dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Xydalba 500mg powder for concentrate for solution for infusion vials (Cardiome UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Dalbavancin true Inferred relationship Existential restriction modifier
Xydalba 500mg powder for concentrate for solution for infusion vials (Cardiome UK Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Xydalba 500mg powder for concentrate for solution for infusion vials (Cardiome UK Ltd) Is a Xydalba true Inferred relationship Existential restriction modifier
Xydalba 500mg powder for concentrate for solution for infusion vials (Cardiome UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Xydalba 500mg powder for concentrate for solution for infusion vials (Cardiome UK Ltd) Has basis of strength substance Dalbavancin true Inferred relationship Existential restriction modifier
Xydalba 500mg powder for concentrate for solution for infusion vials (Cardiome UK Ltd) Has manufactured dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Xydalba 500mg powder for concentrate for solution for infusion vials (Cardiome UK Ltd) Has dispensed dose form Powder for conventional release solution for infusion true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Xydalba 500mg powder for concentrate for solution for infusion vials (Cardiome UK Ltd) 1 vial Has AMP True Xydalba 500mg powder for concentrate for solution for infusion vials (Cardiome UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start